Stockreport

ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]

ImmuCell Corporation  (ICCC) 
US:NASDAQ Investor Relations: immucell.com/investors
PDF subclinical mastitis program, taking a roughly $2.7M non-cash impairment on Re-Tain-related assets. Full-year product sales rose 4.3% to $27.6M and gross margin expand [Read more]